“…[ 6 ] The newborn immune system's immaturity, slow production of endogenous immunoglobulin, absence of maternal transplacental transport of IgG, and defects in the complement system all support the use of effective immunotherapy as adjuvant treatment for neonatal sepsis. [ 7 ] Therefore, Pentaglobin gained great interests in clinical work as adjuvant therapies. [ 8 ] Immunoglobulin is one of the main interconnectable components of the immune system that permit a host to defend against microbial infection.…”